MAINtenance of remission with RITuximab versus azathioprine for patients with newly-diagnosed or relapsing Eosinophilic Granulomatosis with polyangiitis.
A prospective, randomized, controlled, double-blind study: the MAINRITSEG trial.

Contact: xavier.puechal@aphp.fr

Schéma de l'étude MAINRITSEG

Protocole de l'étude

Synopsis

Mis à jour le 29 juillet 2020